Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.
NCT07398508
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Menkes Disease
Interventions
DRUG:
Droxidopa Oral Product
OTHER:
Placebo Control
Sponsor
Stephen G. Kaler